Comparison of Two PD-L1 diagnostic Tests

Comparison of Two PD-L1 diagnostic Tests - Comparison of PD-L1 IHC

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000032178

Enrollment

100

Registered

2018-04-15

Start date

2018-04-08

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-small cell lung cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: NSCLC patients who received complete resection at our institute.

Exclusion criteria

Exclusion criteria: Surgical tissue blocks older than 1 year. Patients who received neoadjubant radiotherapy or chemotherapy.

Design outcomes

Primary

Measure	Time frame
To investigate concordance of the two PD-L1 IHC assay systems (SP263 and 22c3).	—

Countries

Japan

Contacts

Public ContactDaichi Fujimoto

Kobe city medical center general hospital Division of respiratory medicine

daichi@kcho.jp078-302-4321

Outcome results